The Role of Mitochondria-Targeting miRNAs in Intracerebral Hemorrhage

Abstract

Non-traumatic intracerebral hemorrhage (ICH) is the most common type of hemorrhagic stroke, most often occurring between the ages of 45 and 60. Arterial hypertension (AH) is most often the cause of ICH, followed by atherosclerosis, blood diseases, inflammatory changes in cerebral vessels, intoxication and vitamin deficiencies. Cerebral hemorrhage can occur by diapedesis or as a result of a ruptured vessel. AH is difficult to treat; requires surgery and can lead to disability or death. One of the important directions in the study of the pathogenesis of ICH is mitochondrial dysfunction and its regulation. The key role of mitochondrial dysfunction in AH and atherosclerosis, as well as in the development of brain damage after hemorrhage, has been acknowledged. MicroRNAs (miRNAs) are a class of non-coding RNAs (about 18-22 nucleotides) that regulate a variety of biological processes including cell differentiation, proliferation, apoptosis, etc., primarily through gene repression. There is growing evidence to support dysregulated miRNAs in various cardiovascular diseases, including ICH. Further, the realization of miRNAs within mitochondrial compartment has challenged the traditional knowledge of signaling pathways involved in the regulatory network of cardiovascular diseases. However, the role of miRNAs in mitochondrial dysfunction for ICH is still under-appreciated, with comparatively much lesser studies and investigations reported, than those in other cardiovascular diseases. In this review, we summarize the up-to-date findings on the published role miRNAs in mitochondrial function for ICH, and the potential use of miRNAs in clinical settings, such as potential therapeutic targets and non-invasive diagnostic/prognostic biomarker tools.

MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets

“…There are two main pathways in miRNA biogenesis: canonical and non-canonical [ [27] , [28] , [29] , [30] ]. In the canonical pathway, pri-miRNAs undergo processing by DGCR8 and Drosha to form pre-miRNAs, which are then transported to the cytoplasm and further processed by Dicer [ [31] , [32] , [33] ]. Mature miRNA strands are loaded into AGO proteins [ 34 ].…”

Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes

“…Recent research has explored alterations in protein expression linked with mitochondrial function, including OXPHOS, and key elements like PGC-1α, MnSOD, CypD, HIF-1α [34][35][36][37]. Also studied are proteins governing mitochondrial dynamics, such as DRP1, MFN1, MFN2, OPA1, and FIS1 [38][39][40].…”

COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments

“…In vitro miRNAs and lncRNAs against S protein, E protein, M protein, and N protein are able to limit their expression and suppress viral replication in human target cells. The most effective way to inhibit the replication of COVID-19 virus using RNA interference seems to be the impact on multiple regions of the virus genome or a combination of different therapy options [ 96 , 148 ].…”